9-hydroxy-10,12-octadecadienoic acid has been researched along with Lupus Erythematosus, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habazi, D; Han, J; Mohan, C; Saxena, R; Wu, T; Ye, Y; Zhang, T | 1 |
1 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Topics: Autoantibodies; Case-Control Studies; Complement C3; Complement C4; DNA; Humans; Immunoglobulin G; Immunoglobulin M; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Phospholipid Ethers; Severity of Illness Index | 2019 |